Frezyderm Ac-norm Medilike Ef.type2 50ml.

Frezyderm AC-NORM Medilike Effect 2 Cream 50ml | Targeted Acne Care Cream for Moderate Inflammatory Acne

Frezyderm AC-NORM Medilike Effect 2 Cream 50ml is a specialised topical medical device developed for moderate inflammatory papulopustular acne. Formulated for oily and acne-prone skin, it provides targeted care for areas affected by blocked pores, inflammatory blemishes, papules and pustules.

Moderate acne often involves excess sebum, clogged pores and inflamed spots that require a more focused skincare approach. Frezyderm AC-NORM Medilike Effect 2 is specifically designed for Type 2 acne, offering a controlled-release formulation intended to support the management of these concerns.

The cream contains slow-release salicylic acid, an ingredient known for its keratolytic properties. By helping loosen accumulated dead skin cells, salicylic acid supports the removal of material that can contribute to blocked pores. Its controlled-release action is intended to provide targeted care for comedones, papules and pustules.

A distinctive feature of the formulation is its film-forming technology. Once applied, the product creates a thin film over the treated area, allowing its active components to be released gradually through a process described by the manufacturer as sebaceous absorption.

Unlike ordinary cosmetic products designed for occasional blemishes, Frezyderm Medilike Effect 2 is positioned as a medical device for moderate inflammatory acne. It belongs to the AC-NORM collection, developed around the specific requirements of oily, blemish-prone skin.

The manufacturer describes the product as an alternative approach to certain conventional acne treatments, without relying on the same pharmaceutical molecules. It may be used independently or alongside other acne treatments when appropriate and under professional guidance.

The formula is intended for direct application to affected skin once or twice daily, depending on individual requirements, for a maximum recommended period of 30 days. It should not be applied to the eyes or mucous membranes.

Frezyderm AC-NORM Medilike Effect 2 offers a specialised option for individuals seeking targeted care for moderate inflammatory acne. Consistent use according to the manufacturer's directions is important, and persistent or worsening acne should be assessed by a healthcare professional.

Key Features

• Specialised medical device for moderate inflammatory papulopustular acne

• Designed specifically for Type 2 acne and oily, blemish-prone skin

• Formulated with slow-release salicylic acid

• Features film-forming technology for gradual ingredient delivery

• Intended for targeted application over a recommended period of up to 30 days

Key Benefits

• Helps manage acne-prone areas affected by comedones, papules and pustules

• Supports the removal of accumulated dead skin cells through keratolytic action

• Provides controlled delivery of active ingredients to affected areas

• Offers targeted care for moderate inflammatory breakouts

• Can complement an appropriate acne-management routine when used as directed

Key Ingredients

Slow-Release Salicylic Acid: Provides controlled keratolytic action, helping loosen dead skin cells and address blocked pores associated with acne.

Film-Forming Delivery System: Creates a thin film after application, supporting gradual release of the formulation's active components.

The complete ingredient list and concentration of salicylic acid should be checked against the product packaging.

How to Use

Apply Frezyderm AC-NORM Medilike Effect 2 Cream directly to the acne-affected areas.

• Use once or twice daily, depending on the individual case and manufacturer's directions.

• Continue for no longer than the recommended 30-day course unless advised by a healthcare professional.

• Avoid contact with the eyes and mucous membranes.

• Do not use if allergic to any ingredient.

• Store between 15°C and 25°C.

• Keep out of reach of children.

For external use only. Read the medical-device instructions before application. Consult a healthcare professional before combining with prescribed acne treatments.

Formulated Without / Formulation Information

• Classified as a topical medical device in the supplied manufacturer information

• Contains slow-release salicylic acid

• Uses a specialised controlled-release film-forming system

• Developed for moderate inflammatory Type 2 acne

• Intended for a limited application course

The supplied information does not establish specific fragrance-free, alcohol-free or paraben-free claims. Consult the packaging for the complete formulation details and precautions.